Department of Obstetrics and Gynecology, La Sapienza University of Rome, Rome, Italy.
J Sex Med. 2012 Mar;9(3):909-17. doi: 10.1111/j.1743-6109.2011.02581.x.
When cervical cancer is detected at an early stage (International Federation of Gynecology and Obstetrics [FIGO] IA2-IB1), it can be successfully treated by radical surgery alone. Considering that most patients are young and sexually active at the moment of diagnosis and the long life expectancy of survivors after the treatment, quality of life (QoL) and sexual function are important issues for cancer survivors and caregivers. However, only a few studies have examined the QoL and sexual function in disease-free cervical cancer survivors, and there are no studies in the literature comparing prospectively sexual function after different types of radical hysterectomy.
To compare sexual function in two groups of early stage cervical cancer survivors treated by radical surgery alone, undergoing two different types of radical hysterectomy.
Patients treated by radical hysterectomy with systematic lymphadenectomy for early stage cervical cancer (FIGO IA2-IB1) have been enrolled and divided in two groups with regard to type of radical hysterectomy performed; S1: modified radical hysterectomy (Piver II/Type B), S2: classic radical hysterectomy (Piver III/ Type C2).
Twenty-four months after surgery we assessed the sexual function using the European Organization for Research and Treatment of Cancer Cervix Cancer Module Questionnaire, which is a validated system for the assessment of disease- and treatment-specific issues that affect the QoL and sexual functioning of women who are treated for cervical cancer.
Of the 31 patients enrolled in the S1 group and 46 in the S2 group, 23 and 33 patients have been included, respectively. We observed significant differences between the two groups in terms of symptom experience, sexual/vaginal functioning, sexual activity, and sexual enjoyment. There was not any significant difference regarding lymphedema, peripheral neuropathy, and sexual worry.
Survivors of early stage cervical cancer treated by modified radical hysterectomy (Piver II/ Type B) have a better sexual function than those operated by classic radical hysterectomy (Piver III/ Type C2).
当宫颈癌在早期阶段(国际妇产科联合会 [FIGO] IA2-IB1)被发现时,单独进行根治性手术即可成功治疗。考虑到大多数患者在诊断时年轻且具有性活跃性,并且治疗后幸存者的预期寿命较长,因此生活质量(QoL)和性功能是癌症幸存者及其护理人员的重要问题。然而,只有少数研究检查了无病宫颈癌幸存者的 QoL 和性功能,并且在文献中尚无比较两种不同类型根治性子宫切除术治疗后性功能的前瞻性研究。
比较单独接受根治性手术治疗的两组早期宫颈癌幸存者的性功能,这两组患者接受了两种不同类型的根治性子宫切除术。
患有早期宫颈癌(FIGO IA2-IB1)并接受根治性子宫切除术加系统淋巴结切除术的患者被招募,并根据所进行的根治性子宫切除术类型分为两组:S1:改良根治性子宫切除术(Piver II/Type B),S2:经典根治性子宫切除术(Piver III/Type C2)。
手术后 24 个月,我们使用欧洲癌症研究与治疗组织宫颈癌模块问卷评估了性功能,该问卷是一种经过验证的系统,用于评估影响接受宫颈癌治疗的女性生活质量和性功能的疾病和治疗特异性问题。
在 S1 组中纳入了 31 例患者,在 S2 组中纳入了 46 例患者,分别有 23 例和 33 例患者纳入研究。我们观察到两组在症状体验、性/阴道功能、性行为和性享受方面存在显著差异。在淋巴水肿、周围神经病和性担忧方面没有差异。
接受改良根治性子宫切除术(Piver II/Type B)治疗的早期宫颈癌幸存者的性功能优于接受经典根治性子宫切除术(Piver III/Type C2)治疗的幸存者。